Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Alltrna has raised $109.0M in total funding. The most recent round was Series B. The last funding was announced in August 2023.
Alltrna's investors include Flagship Pioneering.
Alltrna is headquartered in Cambridge, United States.
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Alltrna is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alltrna — Funding & Investors." VCBacked, August 9, 2023, https://www.vcbacked.co/company/alltrna. Accessed July 21, 2026.
VCBacked. (2023). Alltrna — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/alltrna
{{cite web |title=Alltrna — Funding & Investors |url=https://www.vcbacked.co/company/alltrna |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated